MaaT Pharma reports positive Phase III results for MaaT013, its microbiome-based therapy for gastrointestinal GvHD, achieving ...

AiCuris appoints Jacques Dumas as CSO to lead research efforts as the company refocuses on infectious disease therapies for ...

Angelini Ventures co-leads a $21 million series A round for Neumirna Therapeutics, supporting its RNA-based therapies for ...

Canadian biotech Aspect Biosystems, which is developing bioprinted tissue therapeutics as a new category in regenerative ...

Insilico Medicine raises over $100 million in series E funding to advance AI-driven drug discovery, including ISM001-055, the ...

Calico Life Sciences, a biotech founded by Alphabet and Arthur Levinson focused on the biology of aging and age-related ...

Privately-held US biotech Alloy Therapeutics has announced a target specific collaboration and license agreement for the use ...

Vertex Pharmaceuticals and Orna Therapeutics announce a $4 billion collaboration to develop in vivo gene editing therapies ...

Antag Therapeutics, a Denmark-based biopharma developing novel treatments for obesity, has announced the appointment of Joerg ...

Denmark’s Novo Nordisk and Valo Health today announced they have entered into an expanded agreement to discover and develop ...

Galapagos plans to split into two entities by mid-2025, focusing its core business on cell therapies while spinning off a new ...

The type 1 diabetes (T1D) market across the seven major markets (7MM: USA, France, Germany, Italy, Spain, the UK, and Japan) ...